FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003293898> ?p ?o ?g. }

• W2003293898 endingPage "600" @default.
• W2003293898 startingPage "595" @default.
• W2003293898 abstract "Background: Terbinafine persists in the nail at effective concentrations for several weeks after discontinuation of treatment. Objective: Our purpose was to verify whether intermittent terbinafine therapy is effective in dermatophytic onychomycosis and to compare the results of intermittent terbinafine with those of intermittent itraconazole and continuous terbinafine treatment. Methods: An open, randomized study of 63 patients was performed with three treatment regimens: terbinafine, 250 mg daily (21 patients); terbinafine, 500 mg daily for 1 week every month (21 patients); or itraconazole, 400 mg daily for 1 week every month (21 patients). Treatment was continued for 4 months in toenail infections (60 patients) and 2 months in fingernail infections (3 patients). Results: At the end of the follow-up period (6 months after discontinuation of treatment) 16 of 17 patients (94.1%) with toenail onychomycosis were mycologically cured in the terbinafine 250 mg group, 16 of 20 (80%) in the terbinafine 500 mg group, and 15 of 20 (75%) in the itraconazole group. Conclusion: The percentage of patients who were mycologically cured was higher in the continuous terbinafine group than in the intermittent terbinafine and itraconazole groups, but statistical analysis did not reveal any significant difference between these cure rates. Terbinafine persists in the nail at effective concentrations for several weeks after discontinuation of treatment. Our purpose was to verify whether intermittent terbinafine therapy is effective in dermatophytic onychomycosis and to compare the results of intermittent terbinafine with those of intermittent itraconazole and continuous terbinafine treatment. An open, randomized study of 63 patients was performed with three treatment regimens: terbinafine, 250 mg daily (21 patients); terbinafine, 500 mg daily for 1 week every month (21 patients); or itraconazole, 400 mg daily for 1 week every month (21 patients). Treatment was continued for 4 months in toenail infections (60 patients) and 2 months in fingernail infections (3 patients). At the end of the follow-up period (6 months after discontinuation of treatment) 16 of 17 patients (94.1%) with toenail onychomycosis were mycologically cured in the terbinafine 250 mg group, 16 of 20 (80%) in the terbinafine 500 mg group, and 15 of 20 (75%) in the itraconazole group. The percentage of patients who were mycologically cured was higher in the continuous terbinafine group than in the intermittent terbinafine and itraconazole groups, but statistical analysis did not reveal any significant difference between these cure rates." @default.
• W2003293898 created "2016-06-24" @default.
• W2003293898 creator A5003600708 @default.
• W2003293898 creator A5011933412 @default.
• W2003293898 creator A5022246846 @default.
• W2003293898 creator A5063790538 @default.
• W2003293898 creator A5063944820 @default.
• W2003293898 creator A5084157436 @default.
• W2003293898 date "1996-04-01" @default.
• W2003293898 modified "2023-10-15" @default.
• W2003293898 title "Treatment of dermatophyte nail infections: An open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy" @default.
• W2003293898 cites W1978623699 @default.
• W2003293898 cites W1987934079 @default.
• W2003293898 cites W2001226629 @default.
• W2003293898 cites W2021374223 @default.
• W2003293898 cites W2025348331 @default.
• W2003293898 cites W2062310715 @default.
• W2003293898 cites W2065164546 @default.
• W2003293898 cites W2112046867 @default.
• W2003293898 doi "https://doi.org/10.1016/s0190-9622(96)80057-0" @default.
• W2003293898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8601647" @default.
• W2003293898 hasPublicationYear "1996" @default.
• W2003293898 type Work @default.
• W2003293898 sameAs 2003293898 @default.
• W2003293898 citedByCount "122" @default.
• W2003293898 countsByYear W20032938982012 @default.
• W2003293898 countsByYear W20032938982013 @default.
• W2003293898 countsByYear W20032938982014 @default.
• W2003293898 countsByYear W20032938982015 @default.
• W2003293898 countsByYear W20032938982016 @default.
• W2003293898 countsByYear W20032938982017 @default.
• W2003293898 countsByYear W20032938982018 @default.
• W2003293898 countsByYear W20032938982019 @default.
• W2003293898 countsByYear W20032938982020 @default.
• W2003293898 countsByYear W20032938982021 @default.
• W2003293898 countsByYear W20032938982022 @default.
• W2003293898 countsByYear W20032938982023 @default.
• W2003293898 crossrefType "journal-article" @default.
• W2003293898 hasAuthorship W2003293898A5003600708 @default.
• W2003293898 hasAuthorship W2003293898A5011933412 @default.
• W2003293898 hasAuthorship W2003293898A5022246846 @default.
• W2003293898 hasAuthorship W2003293898A5063790538 @default.
• W2003293898 hasAuthorship W2003293898A5063944820 @default.
• W2003293898 hasAuthorship W2003293898A5084157436 @default.
• W2003293898 hasConcept C141071460 @default.
• W2003293898 hasConcept C16005928 @default.
• W2003293898 hasConcept C168563851 @default.
• W2003293898 hasConcept C191897082 @default.
• W2003293898 hasConcept C192562407 @default.
• W2003293898 hasConcept C2777071850 @default.
• W2003293898 hasConcept C2777220567 @default.
• W2003293898 hasConcept C2777852167 @default.
• W2003293898 hasConcept C2778236110 @default.
• W2003293898 hasConcept C2778715236 @default.
• W2003293898 hasConcept C2779548794 @default.
• W2003293898 hasConcept C71924100 @default.
• W2003293898 hasConceptScore W2003293898C141071460 @default.
• W2003293898 hasConceptScore W2003293898C16005928 @default.
• W2003293898 hasConceptScore W2003293898C168563851 @default.
• W2003293898 hasConceptScore W2003293898C191897082 @default.
• W2003293898 hasConceptScore W2003293898C192562407 @default.
• W2003293898 hasConceptScore W2003293898C2777071850 @default.
• W2003293898 hasConceptScore W2003293898C2777220567 @default.
• W2003293898 hasConceptScore W2003293898C2777852167 @default.
• W2003293898 hasConceptScore W2003293898C2778236110 @default.
• W2003293898 hasConceptScore W2003293898C2778715236 @default.
• W2003293898 hasConceptScore W2003293898C2779548794 @default.
• W2003293898 hasConceptScore W2003293898C71924100 @default.
• W2003293898 hasIssue "4" @default.
• W2003293898 hasLocation W20032938981 @default.
• W2003293898 hasLocation W20032938982 @default.
• W2003293898 hasOpenAccess W2003293898 @default.
• W2003293898 hasPrimaryLocation W20032938981 @default.
• W2003293898 hasRelatedWork W1968026013 @default.
• W2003293898 hasRelatedWork W1973245611 @default.
• W2003293898 hasRelatedWork W1996950720 @default.
• W2003293898 hasRelatedWork W2029928367 @default.
• W2003293898 hasRelatedWork W2036214634 @default.
• W2003293898 hasRelatedWork W2064532674 @default.
• W2003293898 hasRelatedWork W2147481118 @default.
• W2003293898 hasRelatedWork W2463449047 @default.
• W2003293898 hasRelatedWork W4229676201 @default.
• W2003293898 hasRelatedWork W4244144176 @default.
• W2003293898 hasVolume "34" @default.
• W2003293898 isParatext "false" @default.
• W2003293898 isRetracted "false" @default.
• W2003293898 magId "2003293898" @default.
• W2003293898 workType "article" @default.